Update 2-sanofi Offers $9.3 Bln For Us Cancer Drug Firm Medivation - Reuters

Channel News AsiaUPDATE 2-Sanofi offers $9.3 bln for US cancer drug firm MedivationReuters... * Sanofi makes approach public after Medivation stonewalls. * Deal at $52.50 a share would boost Sanofi EPS immediately. * French drugmaker targeting oncology as priority area (Adds analyst comment, further details). By Leigh Thomas and Ben Hirschler.Sanofi offers $9.3B for Medivation--but the biotech isn't bitingFierceBiotechSanofi makes $9.3 bln takeover bid for MedivationMarketWatchSanofi Offers to Buy Drug Maker Medivation for $9.3 BillionNew York TimesTheStreet.com -Seeking Alpha -Nasdaq -Investor's Business Dailyall 12 news articles »